Azacitidine
- Product NDC
- 43598-143
- 11-digit product format
- 435980143
- Labeler code
- 43598
- Product ID
- 43598-143_bf6007cd-07b7-df87-f778-610cad2941ff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Dr. Reddy's Laboratories Inc.
- Application
- ANDA207234
- Marketing category
- ANDA
- Marketing start
- 2022-04-20
- Marketing end
- 0000-00-00
- Substance
- AZACITIDINE
- Active strength
- 100 mg/50mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43598-143 | AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [DR. REDDY'S LABORATORIES INC.] | 4 | Legacy NDC | 20250119_314faacb-45e7-332e-acc7-b9ff5a475b0c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43598-143-62 | 43598014362 | 1 mL in 1 CARTON (43598-143-62) | 1 ml | 2022-04-20 | 0000-00-00 | No | No | Current |